Here's just a snippet....
The global market size of ovarian cancer is estimated to grow to US$3.6b
by 2010
Each year 73,000 women are diagnosed with ovarian cancer in the US,
Europe, Australia and Japan. 318,000 globally
Of this number, only 10% survive beyond 5 years
A maintenance style treatment like CVac would be the first of its type in
the market and would initially aim to take a conservative 10-25% of this
Cell Therapy A new paradigm
for the treatment of cancer
ovarian cancer treatment market
76% of patients relapse within a year of chemotherapy
Non-toxic nature of CVac creates a no-brainer for the oncologist
A conservative 10% market share equates to approximately US$360m
p.a. Wall St analysts of DNDN suggest market size could be greater than
US$1.5Bn per indication
CVac also has further indications across a number of other cancers
- Forums
- ASX - By Stock
- IMM
- prima - one of the best stocks on asx
prima - one of the best stocks on asx, page-7
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
33.5¢ |
Change
0.025(8.06%) |
Mkt cap ! $486.6M |
Open | High | Low | Value | Volume |
32.0¢ | 34.8¢ | 31.3¢ | $1.379M | 4.179M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 170360 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.0¢ | 115131 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 170360 | 0.330 |
2 | 28172 | 0.325 |
4 | 59365 | 0.320 |
5 | 77800 | 0.310 |
4 | 136393 | 0.305 |
Price($) | Vol. | No. |
---|---|---|
0.340 | 115131 | 3 |
0.345 | 114913 | 6 |
0.350 | 154463 | 8 |
0.355 | 69045 | 5 |
0.360 | 286430 | 5 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |